Following medac and chiron biotechnology?
Get the free weekly contract digest
The latest new contracts, like medac and chiron biotechnology’s — who’s behind them and what they mean, delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New new contracts, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Contract Trends
See who's moving and how much in your market
No credit card required Weekly contract digest
medac and chiron Partner for the Development of Animal-Free Testing Methods
Nov 07, 2024•over 1 year ago
Contract Type
partnership
Schleswig-HolsteinBiotechnologyPharmaceuticalDescription
medac, a global pharmaceutical company, and chiron biotechnology, a Dutch start-up, have announced a promising cooperation for the further development and establishment of animal-free testing methods for the pharmaceutical industry. The partnership aims to test new substances using chiron's advanced organ-on chip technology, which could potentially replace animal testing in drug development.
Agreement Insights
Based on industry dataStrategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months